Principal Investigator
Craig Moskowitz
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20230081
Clinical Trial Summary
A randomised phase III trial with a PET response adapted design comparing ABVD +/- ISRT with A2VD +/- ISRT in patients with previously untreated stage IA/IIA Hodgkin lymphoma
Phase
Phase III
Funding Agency/Sponsor
Institutional
Disease
Lymphoma
Contact Information
Phone Number
305-243-2647